| 영문 | lymphocyte | 한글 | 림프구 |
|---|---|---|---|
| 설명 | 면역기능을 담당하는 세포. 골수에서 만들어지며, 림프구는 크게 2가지로 대분된다. 이른바 T림프세포, B림프세포로 나뉘어지게 된다. T림프세포는 세포성면역에 관여하며, 주로 바이러스병에 대한 면역기능이나, 알레르기(면역반응 4번형 등) 등에 관여한다. 이에 비해 B림프세포는 체액성면역에 관여하여, 항원 항체 반응을 일으키는 항체를 생산하고 주로 세균감염에 대한 면역기능을 담당한다. |
||
| 영문 | T-lymphocyte | 한글 | 티 림프구 |
|---|---|---|---|
| 설명 | 림프계세포(림프구)는 크게 2가지로 대분된다. 이른바 T림프세포(T-cell), B림프세포(B-cell)로 나뉘어진다. T림프세포는 세포성 면역에 관여하며, 주로 바이러스병에 대한 면역기능이나, 알레르기 등에 관여한다. 이에 비해 B림프세포는 체액성 면역에 관여하여, 항원 항체 반응을 일으키는 항체를 생산하고 주로 세균성 질환에 대한 면역 기능을 담당한다. T-림프구는 면역기능에 가장 중요한 역할을 하는 세포로서 세포면역을 담당하며 B-cell의 작용을 조절하는 기능도 있다. 골수에서 생성되어 가슴샘에서 성숙된다. 크게 보조T세포(helper T-cell: 면역작용의 발생을 보조한다)와 T세포(suppressor T-cell: 면역작용의 발생을 억제한다)로 구분되며 이들은 세포 표면에 분포하는 항원에 의해서 식별될 수 있다. |
||
| CTL | cervico-thoraco-lumbar; control; cytolytic C lymphocyte; cytotoxic T-lymphocyte |
|---|---|
| CL | capillary lumen; cardiolipin; cell line; centralis lateralis; chemiluminescence; chest and left arm ... |
| CLMF | cytotoxic lymphocyte maturation factor |
| HLA-LD | human lymphocyte antigen-lymphocyte defined |
| LD | labor and delivery; laboratory data; labyrinthine defect; lactate dehydrogenase; laser Doppler; lear... |
| CTLA-4 | Cytotoxic T Lymphocyte Antigen-4 |
|---|---|
| CTLA-4 | Cytotoxic T lymphocyte associated antigen 4 |
| CTLp | Cytotoxic T lymphocyte precursor |
| CLP | cytotoxic T lymphocyte precursors |
| ADCC | Antibody dependent cellular cytotoxic |
| cytotoxic T lymphocyte-specific serine protease | <enzyme> Structural sequence given in first source Registry number: EC 3.4.21.- Synonym: cytotoxic t lymphocyte-specific serine protease ccp I, cytotoxic t lymphocyte specific serine protease ccp II, mast cell protease type II (26 Jun 1999) |
|---|
| cytotoxic t-lymphocyte | A type of CD8 or, less often, CD4 lymphocyte that kills diseased cells infected by a specific virus or other intracellular microbe. CTLs interact with MHC class I receptors (see Major Histocompatibility Complex). On infected cells and have the prime role in cellmediated immunity (see). Cytovene: See: Ganciclovir. (09 Oct 1997) |
|---|---|
| lymphocyte lymphocyte | A type of non-granular antibodies. (09 Oct 1997) |
| antireticular cytotoxic serum | An antiserum specific for cells of the reticuloendothelial system. (05 Mar 2000) |
| cytotoxic | <pharmacology> Chemicals that are directly toxic to cells, preventing their reproduction or growth. Cytotoxic agents can, as a side effect, damage healthy, noncancerous tissues or organs which have a high proportion of actively dividing cells, for example, bone marrow, hair follicles. These side effects limit the amount and frequency of drug administration. (16 Dec 1997) |
| cytotoxic cell | Cells of the immune system that inhibit or help to terminate an immune response, e.g., suppressor macrophages and suppressor T-cells. Synonym: cytotoxic cell. (05 Mar 2000) |
| cytotoxic drugs | <pharmacology> Anti-cancer drugs which act by killing or preventing the division of cells. See: chemotherapy. (13 Nov 1997) |
| cytotoxic reaction | An immunologic (allergic) reaction in which noncytotropic IgG or IgM antibody combines with specific antigen on cell surfaces; the resulting complex initiates the activation of complement which causes cell lysis or other damage, or which, in the absence of complement, may lead to phagocytosis or may enhance T lymphocyte involvement. (05 Mar 2000) |
| cytotoxic T-cell | <haematology, immunology> Subset of T lymphocytes (mostly CD8) responsible for lysing target cells and for killing virus infected cells (in the context of Class I histocompatibility antigens). (18 Nov 1997) |
| T cytotoxic cells | Lymphocyte-like effector cells which mediate antibody-dependent cell cytotoxicity. They kill antibody-coated target cells which they bind with their fc receptors. (12 Dec 1998) |
| T-lymphocytes, cytotoxic | Immunised T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (mlc), in vivo during a graft-versus-host (gvh) reaction, or after immunization with an allograft, tumour cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (cml). These cells are distinct from natural killer cells (killer cells, natural) and from killer cells mediating antibody-dependent cell cytotoxicity. (12 Dec 1998) |
| antigens, differentiation, b-lymphocyte | Membrane antigens associated with maturation stages of B-lymphocytes, often expressed in tumours of B-cell origin. (12 Dec 1998) |
| antigens, differentiation, t-lymphocyte | Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function. (12 Dec 1998) |
| bare lymphocyte syndrome | <syndrome> Absence of HLA antigens on peripheral mononuclear cells, which may result in immunodeficiency. (05 Mar 2000) |
| B lymphocyte | <haematology, immunology> An immunologically important lymphocyte, produced by the bone marrow, that is responsible for the production of immunoglobulins, it is the precursor of the plasma cell. The surface markers can be used to detect and differentiate chronic lymphocytic leukaemia from acute lymphocytic leukaemia. (13 Nov 1997) |
| b-lymphocyte subsets | A classification of B-lymphocytes based on structurally or functionally different populations of cells. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|